331852009: Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Product manufactured as cutaneous dose form (product)\Product containing clioquinol in cutaneous dose form (medicinal product form)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Product manufactured as cutaneous dose form (product)\Betamethasone-containing product in cutaneous dose form\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment

\Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing betamethasone (medicinal product)\Betamethasone-containing product in cutaneous dose form\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing only betamethasone and clioquinol (medicinal product)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing clioquinol (medicinal product)\Product containing clioquinol in cutaneous dose form (medicinal product form)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing clioquinol (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing only betamethasone and clioquinol (medicinal product)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing clioquinol (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Betamethasone-containing product in cutaneous dose form\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing only betamethasone and clioquinol (medicinal product)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Betamethasone-containing product in cutaneous dose form\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing only betamethasone and clioquinol (medicinal product)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment

\Medicinal product categorized by structure\Product containing steroid (product)\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Betamethasone-containing product in cutaneous dose form\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing only betamethasone and clioquinol (medicinal product)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Betamethasone-containing product in cutaneous dose form\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing only betamethasone and clioquinol (medicinal product)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Betamethasone-containing product in cutaneous dose form\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing only betamethasone and clioquinol (medicinal product)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quinoline (product)\Product containing oxyquinoline structure (product)\Product containing clioquinol (medicinal product)\Product containing clioquinol in cutaneous dose form (medicinal product form)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quinoline (product)\Product containing oxyquinoline structure (product)\Product containing clioquinol (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing only betamethasone and clioquinol (medicinal product)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quinoline (product)\Product containing oxyquinoline structure (product)\Product containing clioquinol (medicinal product)\Product containing betamethasone and clioquinol (medicinal product)\Product containing betamethasone and clioquinol in cutaneous dose form (medicinal product form)\Betamethasone and clioquinol only product in cutaneous dose form\Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3692852011 Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3692853018 Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Is a	Product containing betamethasone and clioquinol (medicinal product)	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Betamethasone	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Adrenal hormone	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Corticosterone	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Adrenal hormone agent	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	agent cutané	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Skin antifungal agent	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Hydroxychloroquine (substance)	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Hydrocortisone (substance)	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Clioquinol (substance)	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Local anti-infective	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	agent cutané	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Has manufactured dose form	forme pharmaceutique pour usage transdermique et/ou cutané	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Glucocorticoid hormone	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Has manufactured dose form	A semi-solid dose form consisting of a single-phase in which solids or liquids may be dissolved or dispersed in the base, which may be hydrophilic, hydrophobic or water-emulsifying.	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Has manufactured dose form	Cutaneous ointment	true	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Is a	Product containing clioquinol in topical dosage form	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	This attribute specifies the denominator unit for the concentration strength of a product.	g	true	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Is a	Product containing betamethasone valerate in topical dosage form	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	This attribute specifies the denominator unit for the concentration strength of a product.	g	true	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Has concentration strength denominator value	un	false	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Count of base of active ingredient	deux	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Has concentration strength denominator value	un	false	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Clioquinol (substance)	true	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Has concentration strength numerator value	30	false	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Clioquinol (substance)	true	Inferred relationship	Some	2
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Betamethasone	true	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Has concentration strength numerator value	un	false	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Betamethasone valerate (substance)	true	Inferred relationship	Some	1
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Is a	Betamethasone and clioquinol only product in cutaneous dose form	true	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Plays role	Antiprotozoal therapeutic role	false	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	Plays role	Antifungal therapeutic role (role)	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3692852011	Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3692853018	Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core